A formulation comprising: a) a dendron of Formula I, wherein R is selected from the group consisting of hydrogen, halogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 alkoxy, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl, C 2-16 alkenyl, C 2-16 alkynyl, -COOR a, -C R b, -C NR b R c, -NR d R e, -NR b C R c, -OC R b, wherein R a is selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl; R b and R c are independently selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl; R d and R e are independently selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl, wherein 'n' is in the range of 1-15; the branch growth follows a dendritic pattern; all groups of all repeating units are attached to another repeating unit till the penultimate repeating unit of every branch, and the groups of the terminal repeating units of all branches are attached to an atom or a functional group independently selected from the group consisting of hydrogen, tert-butyloxycarbonyl (Boc), and fluorenylmethyloxycarbonyl (Fmoc); b) at least one bio-therapeutic, wherein the bio-therapeutic is selected from the group consisting of monoclonal antibodies; c) at least one buffer solution, wherein the buffer solution is selected from the group consisting of phosphate buffer, citrate buffer, acetate buffer, histidine buffer, succinate buffer, and glycine buffer; and d) at least one salt, wherein the salt is selected from the group consisting of sodium chloride, potassium chloride, calcium chloride, potassium iodide, magnesium chloride, magnesium sulfate, sodium citrate, and sodium acetate, wherein the bio-therapeutic to the dendron molar ratio is in the range of 1:0.5-1:3. a) a dendron of Formula I, wherein R is selected from the group consisting of hydrogen, halogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 alkoxy, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl, C 2-16 alkenyl, C 2-16 alkynyl, -COOR a, -C R b, -C NR b R c, -NR d R e, -NR b C R c, -OC R b, wherein R a is selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl; R b and R c are independently selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl; R d and R e are independently selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl, wherein 'n' is in the range of 1-15; the branch growth follows a dendritic pattern; all groups of all repeating units are attached to another repeating unit till the penultimate repeating unit of every branch, and the groups of the terminal repeating units of all branches are attached to an atom or a functional group independently selected from the group consisting of hydrogen, tert-butyloxycarbonyl (Boc), and fluorenylmethyloxycarbonyl (Fmoc); wherein R is selected from the group consisting of hydrogen, halogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 alkoxy, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl, C 2-16 alkenyl, C 2-16 alkynyl, -COOR a, -C R b, -C NR b R c, -NR d R e, -NR b C R c, -OC R b, wherein R a is selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl; R b and R c are independently selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl; R d and R e are independently selected from the group consisting of hydrogen, C 1-16 alkyl, C 5-22 aryl, C 1-16 haloalkyl, C 3-12 cycloalkyl, C 1-20 heteroaryl, C 1-20 heterocyclyl, wherein 'n' is in the range of 1-15; the branch growth follows a dendritic pattern; all groups of all repeating units are attached to another repeating unit till the penultimate repeating unit of every branch, and the groups of the terminal repeating units of all branches are attached to an atom or a functional group independently selected from the group consisting of hydrogen, tert-butyloxycarbonyl (Boc), and fluorenylmethyloxycarbonyl (Fmoc); b) at least one bio-therapeutic, wherein the bio-therapeutic is selected from the group consisting of monoclonal antibodies; c) at least one buffer solution, wherein the buffer solution is selected from the group consisting of phosphate buffer, citrate buffer, acetate buffer, histidine buffer, succinate buffer, and glycine buffer; and d) at least one salt, wherein the salt is selected from the group consisting of sodium chloride, potassium chloride, calcium chloride, potassium iodide, magnesium chloride, magnesium sulfate, sodium citrate, and sodium acetate,